Specifically, on November 3, 2016, Bloomberg published the article titled "U.S. Charges in Generic-Drug Probe to Be Filed by Year End" which discussed the DOJ's two year investigation of suspected price collusion by several pharmaceutical companies. The article included Lannett among the companies being investigated and it also states that the investigation will likely result in prosecutors filing criminal charges by the end of the year.
On these news, Lannett's share price fell from $2.350 per share on November 2, 2016 to a closing price of $17.25 on November 3, 2016—a $6.25 or a 26.6% drop.
Request more information now by clicking here: www.faruqilaw.com/LCI. There is no cost or obligation to you.
If you invested in Lannett common stock and options and would like to discuss your legal rights, visit www.faruqilaw.com/LCI. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Lannett's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
Telephone: (877) 247-4292 or (212) 983-9330
Logo - http://photos.prnewswire.com/prnh/20120119/MM38856LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lannett-notification-faruqi--faruqi-llp-encourages-investors-who-suffered-losses-in-excess-of-100000-investing-in-lannett-company-inc-to-contact-the-firm-300362525.html
SOURCE Faruqi & Faruqi, LLP